Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Cheung

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
World Journal of Gastroenterology|December 12, 2003
Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatmentHenry Lik-Yuen Chan, May-Ling Wong, Alex Yui Hui, et al.
Annals of Internal Medicine|February 16, 2005
A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine aloneHenry Lik-Yuen Chan, Nancy Wai-Yee Leung, Alex Yui Hui, et al.
Gastroenterology|May 19, 2009
High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcersGrace Lai-Hung Wong, Vincent Wai-Sun Wong, Yawen Chan, et al.
Frontiers in Immunology|June 21, 2023
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinomaChun Chau Lawrence Cheung, Yong Hock Justin Seah, Juntao Fang, et al.
Gut|June 4, 2021
Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19Chun Chau Lawrence Cheung, Denise Goh, Xinru Lim, et al.
Lancet (London, England)|May 15, 2007
Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trialFrancis Ka Leung Chan, Vincent Wai Sun Wong, Bing Yee Suen, et al.
Journal for Immunotherapy of Cancer|August 16, 2023
Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinomaNeslihan Arife Kaya, David Tai, Xinru Lim, et al.
Frontiers in Immunology|September 29, 2022
Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity <i>via</i> spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbidityMai Chan Lau, Yang Yi, Denise Goh, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
World Journal of Gastroenterology|December 12, 2003
Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatmentHenry Lik-Yuen Chan, May-Ling Wong, Alex Yui Hui, et al.
Annals of Internal Medicine|February 16, 2005
A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine aloneHenry Lik-Yuen Chan, Nancy Wai-Yee Leung, Alex Yui Hui, et al.
Gastroenterology|May 19, 2009
High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcersGrace Lai-Hung Wong, Vincent Wai-Sun Wong, Yawen Chan, et al.
Frontiers in Immunology|June 21, 2023
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinomaChun Chau Lawrence Cheung, Yong Hock Justin Seah, Juntao Fang, et al.
Gut|June 4, 2021
Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19Chun Chau Lawrence Cheung, Denise Goh, Xinru Lim, et al.
Lancet (London, England)|May 15, 2007
Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trialFrancis Ka Leung Chan, Vincent Wai Sun Wong, Bing Yee Suen, et al.
Journal for Immunotherapy of Cancer|August 16, 2023
Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinomaNeslihan Arife Kaya, David Tai, Xinru Lim, et al.
Frontiers in Immunology|September 29, 2022
Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity <i>via</i> spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbidityMai Chan Lau, Yang Yi, Denise Goh, et al.
Pageof 4